Very early MS - insights from MRI

被引:10
|
作者
Simon, Jack [1 ]
机构
[1] Portland VA Med Ctr, Portland, OR 97239 USA
关键词
Clinically isolated syndrome; multiple sclerosis; magnetic resonance imaging; atrophy; gray matter; CLINICALLY ISOLATED SYNDROME; GRAY-MATTER ATROPHY; RADIOLOGICALLY ISOLATED SYNDROME; MULTIPLE-SCLEROSIS; GREY-MATTER; DIAGNOSTIC-CRITERIA; WHITE-MATTER; FOLLOW-UP; LESIONS; CONVERSION;
D O I
10.1177/1352458512452925
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Magnetic resonance imaging (MRI) is likely to play an increasing role in efforts to understand the earliest changes in multiple sclerosis (MS) and narrowing the gap to new insights provided by the recent pathology literature showing early meningeal and cortical inflammatory disease and cortical gray matter demyelination. Much of the insight into early MS already comes from MRI as it evaluates patients at the time of a clinically isolated syndrome (CIS). Series show transition of tissue from normal to abnormal, and now often reveal gray matter more so than white matter pathology, deep gray more than cortical gray, and quantitative MRI changes preceding atrophy in early MS. But the CIS population is heterogeneous, likely including patients with many years' duration, as well as relatively recent onset disease. Efforts to evaluate earlier disease, possibly sub-populations of CIS, patients at risk for MS with strict criteria for a radiologically isolated syndrome, and tumefactive MS, combined with advanced MRI technology, may bring us closer to in vivo insight into truly early or earliest MS.
引用
收藏
页码:1372 / 1376
页数:5
相关论文
共 50 条
  • [21] Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis
    Conaghan, Philip G.
    Ostergaard, Mikkel
    Troum, Orrin
    Bowes, Michael A.
    Guillard, Gwenael
    Wilkinson, Bethanie
    Xie, Zhiyong
    Andrews, John
    Stein, Amy
    Chapman, Douglass
    Koenig, Andrew
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
  • [22] Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment
    Cramer, Stig P.
    Hamrouni, Nizar
    Simonsen, Helle J.
    Vestergaard, Mark B.
    Varatharaj, Aravinthan
    Galea, Ian
    Lindberg, Ulrich
    Frederiksen, Jette Lautrup
    Larsson, Henrik B. W.
    FRONTIERS IN NEUROSCIENCE, 2025, 19
  • [23] MRI USED TO MONITOR EFFICACY OF EARLY TREATMENT OF R/R MS
    SMITH, ME
    STONE, LA
    FRANK, JA
    ALBERT, P
    MALONI, H
    NAVEAU, I
    PORTER, J
    ARMSTRONG, M
    MCFARLIN, DE
    MCFARLAND, HF
    NEUROLOGY, 1993, 43 (04) : A183 - A183
  • [24] Insights into Rheumatoid Arthritis from Use of MRI
    McQueen, Fiona M.
    Chan, Estee
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (01)
  • [25] Deep Multimodal Learning From MRI and Clinical Data for Early Prediction of Neurodevelopmental Deficits in Very Preterm Infants
    He, Lili
    Li, Hailong
    Chen, Ming
    Wang, Jinghua
    Altaye, Mekibib
    Dillman, Jonathan R.
    Parikh, Nehal A.
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [26] Insights into Rheumatoid Arthritis from Use of MRI
    Fiona M. McQueen
    Estee Chan
    Current Rheumatology Reports, 2014, 16
  • [27] Interesting Insights from a Very Simple (Unicellular) Source
    Lynch, Carl, III
    ANESTHESIA AND ANALGESIA, 2010, 110 (01): : 1 - 3
  • [28] Access, timing and frequency of very early stroke rehabilitation – insights from the Baden-Wuerttemberg stroke registry
    Björn Reuter
    Christoph Gumbinger
    Tamara Sauer
    Horst Wiethölter
    Ingo Bruder
    Curt Diehm
    Peter A. Ringleb
    Werner Hacke
    Michael G. Hennerici
    Rolf Kern
    BMC Neurology, 16
  • [29] Access, timing and frequency of very early stroke rehabilitation - insights from the Baden-Wuerttemberg stroke registry
    Reuter, Bjoern
    Gumbinger, Christoph
    Sauer, Tamara
    Wiethoelter, Horst
    Bruder, Ingo
    Diehm, Curt
    Ringleb, Peter A.
    Hacke, Werner
    Hennerici, Michael G.
    Kern, Rolf
    BMC NEUROLOGY, 2016, 16
  • [30] MS treatment profiles in Germany - insights from two major MS cohorts
    Ellenberger, D.
    Gisevius, B.
    Motte, J.
    Flachenecker, P.
    Gold, R.
    Haas, J.
    Hellwig, K.
    Timmesfeld, N.
    Wiendl, H.
    Zettl, U.
    Stahmann, A.
    Salmen, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 697 - 699